中国育龄女性针对性戊肝疫苗接种具有成本效果
在中国育龄女性中构建决策树-Markov模型,模拟戊肝病毒感染,比较直接接种与筛查后接种两种策略。结果显示两种策略的ICER均低于1倍人均GDP,筛查后接种更具成本效果。
要点
- 直接接种和筛查后接种的ICER分别为每避免1个DALY $4040和$3114,均低于1倍人均GDP($8127)。
- 筛查后接种相比直接接种,每避免1个DALY需额外$45,455,远超3倍人均GDP。
- 概率敏感性分析确认,当支付意愿达到1倍人均GDP时,两种策略均具成本效果,筛查后接种更优。
核心结论
- 在中国育龄女性中接种HEV 239,每避免1个DALY的成本低于1倍人均GDP,且筛查后接种为最优选项。
研究设计与样本
- 构建决策树-Markov模型,模拟平均初婚年龄25岁的封闭女性队列中HEV感染,从社会视角评估直接接种和筛查后接种两种策略。
主要发现
- 直接接种和筛查后接种对比不接种的ICER分别为每避免1个DALY $4040和$3114,均远低于1倍人均GDP($8127)。
- 筛查后接种相比直接接种,每避免1个DALY需额外$45,455,远高于3倍人均GDP。
- 概率敏感性分析显示,当支付意愿达到1倍人均GDP时,两种策略均具成本效果,筛查后接种更具成本效果。
关键数值与推荐
- ICER阈值参考:1倍人均GDP为$8127,3倍人均GDP未报告具体数值。
临床怎么用
- 育龄女性接种戊肝疫苗HEV 239具有成本效果,推荐采用先筛查抗体再接种的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hepatitis E virus (HEV) infection is hyper-endemic in China, it is characterized with a high morbidity of fulminant hepatitis and mortality in pregnant women. The first hepatitis E vaccine, HEV 239, was licensed in China in 2011 which provides an effective preventive measure. OBJECTIVE: To evaluate the cost-effectiveness of vaccination with HEV 239 in women of childbearing age in China and whether HEV antibody screening should be considered before vaccination. METHODS: A decision tree-Markov model was constructed to simulate HEV infection in a closed female cohort with an average first-marriage age of 25 years and evaluate health and economic outcomes of two potential vaccination strategies, direct vaccination and combined screening and vaccination, from a societal perspective. An incremental cost-effectiveness ratio (ICER, additional costs per disability-adjusted life-year (DALY) averted) was calculated for each vaccination strategy versus no vaccination and between two vaccination strategies. Univariate and probabilistic sensitivity analyses were conducted to assess the robustness of the model findings. RESULTS: ICERs of direct vaccination and combined screening and vaccination versus no vaccination were $4040 and $3114 per DALY averted, respectively, much lower than 1-time Chinese per-capita GDP ($8127). Direct vaccination would need additional $45,455 for each DALY averted compared with combined screening and vaccination, far more than the 3-time per-capita GDP. Probabilistic sensitivity analyses confirmed our findings that two vaccination strategies would be cost-effective if the willingness-to-pay reached the 1-time per-capita GDP, and that combined screening and vaccination would be more cost-effective than direct vaccination strategy. CONCLUSION: Vaccinating women of childbearing age with HEV 239 would cost less than the 1-time per-capita GDP for each DALY averted in China, and the vaccination with a prior screening would be the optimal option.
引用
- Xia R, Sun S, Shen M, et al. Targeted hepatitis E vaccination for women of childbearing age is cost-effective in China. Vaccine. 2019. PMID: 31443991. doi:10.1016/j.vaccine.2019.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。